DOGS · Condition guide
Atopic dermatitis in dogs: real veterinary cases
Canine atopic dermatitis is a lifelong allergic skin disease — the dog's immune system reacts to ordinary environmental allergens like pollens, dust mites, and moulds. It usually starts between 6 months and 3 years of age, often shows clear seasonality at first, and over time progresses to year-round itching with recurrent ear and skin infections.
Diagnosis is clinical and one of exclusion: rule out fleas, mites, and food allergy, then what's left is atopy. Modern treatment is a multi-modal toolkit — symptomatic relief (Apoquel, Cytopoint, steroids), barrier support (omega-3s, medicated shampoos), and disease-modifying allergen-specific immunotherapy (ASIT). Most dogs do very well long-term.
What vets typically check for
- Rigorous flea control (isoxazolines, year-round) — fleas are still the #1 missed cause.
- 8-week strict elimination diet to rule out adverse food reaction.
- Treat any concurrent skin or ear infections (Staph, Malassezia).
- Once atopy is confirmed: choose between symptomatic (Apoquel, Cytopoint) and disease-modifying (immunotherapy).
- Intradermal or serological allergy testing to formulate immunotherapy if elected.
Not a replacement for veterinary care. Use this to walk into the conversation prepared, not to self-diagnose.
Real cases from the veterinary literature
Peer-reviewed reports our semantic search surfaces for Canine atopic dermatitis. Click into any case for the full abstract — or run a personalised search with your pet's exact details.
- Assessing D-Squame as a Minimally Invasive Technique to Evaluate the Cutaneous Immune Response mRNA in a Dog Model of Canine Atopic Dermatitis.
Veterinary dermatology · 2026 · France
A group of eight healthy beagles was tested for skin allergies using a new, less invasive method called D-Squame, which involves tape stripping to collect skin samples. The dogs were exposed to house dust mites for seven weeks to see how their skin reacted. Researchers found that certain genes related to the immune response were significantly affected by the exposure, which cou
- Efficacy of Combination Oclacitinib and Lokivetmab Therapies After Monotherapeutic Failure in 44 Dogs: A Retrospective Study.
Veterinary dermatology · 2026 · United States
A group of 44 dogs with allergic dermatitis that didn't improve with either oclacitinib or lokivetmab were treated with a combination therapy of both medications. After starting this combination treatment, 27 of the dogs showed significant improvement, with their itching scores dropping from an average of 6.87 to 2.67 out of 10. This means that more than half of the dogs experi
- Chronic exfoliative dermatitis in a German Shorthaired Pointer dog
Brazilian Journal of Veterinary Pathology · 2026
A 5-year-old spayed female German Shorthaired Pointer was taken to the vet for a second opinion due to ongoing skin problems that were suspected to be caused by allergies. The dog's condition improved when treated with prednisone, a steroid that helps reduce inflammation, but she did not respond to antibiotics or a medication called oclacitinib (Apoquel). The skin issues starte
- Some of the Newest Therapeutic Methods in Canine Atopic Dermatitis
Veterinary Sciences · 2026
A dog with chronic itching and skin problems due to atopic dermatitis (a hereditary skin condition) may need long-term treatment to manage their symptoms. There are several options available, including medications like glucocorticoids, cyclosporine A, and newer treatments like Janus kinase inhibitors and lokivetmab. It's important for pet owners to work closely with their veter
- Endogenous calcitriol production and ionized hypercalcemia in 7 dogs with chronic dermatopathy of infectious and noninfectious etiology (2016-2024).
Journal of veterinary internal medicine · 2026 · United States
A group of 7 dogs with chronic skin problems, including conditions like panniculitis and mange, were found to have high calcium levels in their blood. This hypercalcemia (high calcium) was linked to excessive production of calcitriol, a form of vitamin D, rather than issues with their parathyroid glands. After receiving treatment for their skin conditions, all the dogs showed i
- Oclacitinib modulates IL-2 driven T-cell activation through CD25 regulation: A comparative analysis with prednisolone.
Veterinary immunology and immunopathology · 2026 · United States
A study looked at how two medications, oclacitinib and prednisolone, affect T-cells in dogs with canine atopic dermatitis, a skin condition caused by allergies. The researchers found that oclacitinib reduced certain markers on T-cells that are involved in inflammation, while prednisolone did not have the same effect. This suggests that oclacitinib may be more effective in manag
Frequently asked questions
- What's the difference between Apoquel and Cytopoint?
- Apoquel (oclacitinib) is a daily oral JAK-inhibitor — fast onset, very effective. Cytopoint (lokivetmab) is a monthly injectable monoclonal antibody specifically against canine IL-31. Many dogs do well on either; some respond better to one than the other.
- Does immunotherapy work?
- It's the only treatment that actually modifies the disease rather than masking the itch. Roughly 60-70% of dogs improve significantly on a properly-formulated immunotherapy course given over months to years. It's a long game but worth it for many cases.
- Will diet change cure it?
- Only if the dog has a concurrent food allergy. Most atopic dogs are not primarily food-allergic, but ~20% have both. A proper diet trial rules food in or out and is always step one.